Friday, July 10, 2026

pharma · Hemophilia · Gaucher's disease type I; Gaucher's disease type III

Genzyme Europe

Genzyme Europe trial registry — 5 ClinicalTrials.gov studies with program phase, status, and indication context.

NL HQ
1981 Founded
273 Employees
EMA registrant Type
Company details
Status
Public
HQ
NL
Founded
1981
Employees
273
Programs
5
Drugs
10
Patents
0
Intelligence · Clinical Trials

Genzyme Europe clinical trials

Registry index of 5 ClinicalTrials.gov studies linked to Genzyme Europe programs — each row shows trial ID, program name, phase, status, and indication.

Genzyme Europe trial registry — 5 ClinicalTrials.gov studies with program phase, status, and indication context.

Recent trial activity

5 updates

Latest clinical program signals indexed for Genzyme Europe.

  1. EFC16035 — Phase 3

    Clinical update
  2. PDY13949 — Phase 2

    Clinical update
  3. LTE15174 — Phase 3

    Clinical update
  4. EFC13738 — Phase 3

    Clinical update
  5. SAR439774 — Phase 3

    Clinical update

Trial registry

5 studies